Table 1.
Population characteristics
| Patient characteristics | |
|---|---|
| Number of patients | 351 |
| Age, median (IQR) | 58 (50–63) |
| Gender, male (%) | 223 (64) |
| PICC characteristics | |
|---|---|
| Number of episodes | 455 |
| Hematologic condition, n (%) | |
| Multiple myeloma | 122 (27) |
| Acute myeloid leukaemia | 118 (26) |
| Non-Hodgkin lymphoma | 103 (23) |
| Acute lymphoblastic leukaemia | 46 (10) |
| Myelodysplastic syndrome | 15 (3) |
| Hodgkin lymphoma | 11 (2) |
| Aplastic anaemia | 10 (2) |
| Chronic myeloid leukaemia | 8 (2) |
| Chronic myelomonocytic leukaemia | 7 (2) |
| Myeloproliferative neoplasms | 6 (1) |
| Chronic lymphocytic leukaemia | 5 (1) |
| Othera | 4 (1) |
| SCT, n (%) | 220 (48) |
| Autologous | 164 (75) |
| Allogeneic | 56 (25) |
| Chemotherapy | 219 (48) |
| Supportive care | 16 (4) |
| Duration of placement in minutes, median (IQR)b | 30 (30–45) |
| Repositioning after placement, n (%)* | 126 (28) |
| Insertion in right arm, n (%) | 367 (81) |
| Number of lumens, n (%) | |
| Single lumen | 53 (12) |
| Double lumen | 368 (81) |
| Triple lumen | 34 (8) |
| PICC line rank, n (%) | |
| First | 343 (75) |
| Second | 89 (20) |
| Third or more | 23 (5) |
| Catheter days, median (range) | 26 (21-57) |
| Total parenteral nutrition, n (%) | 52 (11) |
| Duration in days, median (range) | 9.5 (6–19) |
IQR, interquartile range; SCT, stem cell transplantation
*20 episodes had missing data
aBlastic Plasmocytoid Dendritic Cell Neoplasm (n = 2), Systemic sclerosis (n = 1) and Hairy Cell Leukaemia (n = 1)
b9 episodes had missing data
cχ2 not significant